dc.contributor.author |
Vlasov, Lilia |
|
dc.date.accessioned |
2020-05-09T17:21:29Z |
|
dc.date.available |
2020-05-09T17:21:29Z |
|
dc.date.issued |
2011 |
|
dc.identifier.citation |
VLASOV, L. Evidenţierea aspectelor fiziopatologice ale sindromului hepato-renal la pacienţii cu ciroză hepatică. In: Arta Medica. 2011, nr. 2(45), pp. 285-287. ISSN 1810-1852. |
en_US |
dc.identifier.issn |
1810-1852 |
|
dc.identifier.uri |
http://repository.usmf.md/handle/20.500.12710/9292 |
|
dc.description |
Catedra de Medicină Internă Nr.5 USMF ,,N. Testemiţanu”, Secţia Nefrologie şi Hemodializă IMSP SCM ”Sfânta Treime”, Al V-lea Congres de Urologie, Dializă şi Transplant Renal din Republica Moldova cu participare internaţională (1-13 iunie 2011) |
en_US |
dc.description.abstract |
Summary. Hepato-renal syndrome is caused by renal vasoconstriction and impaired glomerular perfusion, both of which may be mediated by increased formation of vasoactive mediators such as endotelin-1 and decreased plasma prostaglandin E-2 production. The plasma endothelin (ET) and PGE-2 levels were evaluated in 114 patients with hepatic cirrhosis, including 23 patients with hepato-renal syndrome. The determination of ET-1, PGE-2 and urinary enzymes can be included in the prognostic assessment of patient with decompensate cirrhosis and hepato-renal syndrome. |
en_US |
dc.language.iso |
ro |
en_US |
dc.publisher |
Asociaţia chirurgilor “Nicolae Anestiadi” din Republica Moldova |
en_US |
dc.subject.mesh |
Liver cirrhosis - physiopathology |
en_US |
dc.subject.mesh |
Hepatorenal syndrome - physiopathology |
en_US |
dc.subject.mesh |
Liver cirrhosis--diagnosis |
en_US |
dc.title |
Evidenţierea aspectelor fiziopatologice ale sindromului hepato-renal la pacienţii cu ciroză hepatică |
en_US |
dc.title.alternative |
Pathways of pathophysiologic mechanisms in patients with hepatic cirrhosis and hepato-renal syndrome |
en_US |
dc.type |
Article |
en_US |